Cargando…

Comparison of GFAP and UCH-L1 Measurements from Two Prototype Assays: The Abbott i-STAT and ARCHITECT Assays

Glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) may aid in the evaluation of traumatic brain injury (TBI). The objective of this analysis was to compare GFAP and UCH-L1 values measured using a handheld device compared with a core laboratory platform. We a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korley, Frederick K., Datwyler, Saul A., Jain, Sonia, Sun, Xiaoying, Beligere, Gangamani, Chandran, Raj, Marino, Jaime A., McQuiston, Beth, Zhang, Hongwei, Caudle, Krista L., Wang, Kevin K.W., Puccio, Ava M., Okonkwo, David O., Yue, John K., Taylor, Sabrina R., Markowitz, Amy, Manley, Geoffrey T., Diaz-Arrastia, Ramon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086519/ https://www.ncbi.nlm.nih.gov/pubmed/33937911 http://dx.doi.org/10.1089/neur.2020.0037

Ejemplares similares

Verification of Abbott 25-OH-vitamin D assay on the architect system
por: Hutchinson, Katrina, et al.
Publicado: (2017)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
por: Lau, Chin-Shern, et al.
Publicado: (2022)

Sex difference in the discordance between Abbott Architect and EuroImmun serological assays
por: Hartsell, Joel D., et al.
Publicado: (2023)

Evaluation of Acute Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Plasma Levels in Traumatic Brain Injury Patients with and without Intracranial Lesions
por: Biberthaler, Peter, et al.
Publicado: (2021)

Assessment of Abbott Architect 25-OH vitamin D assay in different levels of vitamin D
por: Avci, Esin, et al.
Publicado: (2020)

Kinetics and performance of the Abbott architect SARS-CoV-2 IgG antibody assay
por: Hamilton, Fergus, et al.
Publicado: (2020)

Comparison between Roche Integra 400 plus and Abbott Architect ci8200 in Alanine aminotransferase assay
por: Lamrabat, Somiya, et al.
Publicado: (2019)

Evaluation of the Abbott ARCHITECT HIV Ag/Ab combo assay for determining recent HIV-1 infection
por: Curtis, Kelly A., et al.
Publicado: (2021)

Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho
por: Bryan, Andrew, et al.
Publicado: (2020)

Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients
por: Ren, Changhong, et al.
Publicado: (2016)

Longitudinal evaluation of the Abbott ARCHITECT SARS-CoV-2 IgM and IgG assays in a pediatric population
por: Interiano, Cristina, et al.
Publicado: (2021)

Reference intervals established using indirect method for serum ferritin assayed on Abbott Architect i2000(SR) analyzer in Chinese adults
por: Wang, Qing‐ping, et al.
Publicado: (2019)

A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay
por: Batra, Rahul, et al.
Publicado: (2020)

Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems
por: Soh, A., et al.
Publicado: (2018)

Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays
por: Lau, C.S., et al.
Publicado: (2021)

Dataset for longitudinal evaluation of the Abbott ARCHITECT SARS-CoV-2 IgM and IgG assays in a pediatric population divided by age
por: Interiano, Cristina, et al.
Publicado: (2021)

Accuracy of a rapid glial fibrillary acidic protein/ubiquitin carboxyl‐terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury
por: Bazarian, Jeffrey J., et al.
Publicado: (2021)

Comparison of the SARS-CoV-2 spike protein ELISA and the Abbott Architect SARS-CoV-2 IgG nucleocapsid protein assays for detection of antibodies
por: Wadhwa, Ashutosh, et al.
Publicado: (2021)

Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assays
por: Boler, Michael, et al.
Publicado: (2023)

UCH-L1 and GFAP Serum Levels in Neonates with Hypoxic–Ischemic Encephalopathy: A Single Center Pilot Study
por: Douglas-Escobar, Martha V., et al.
Publicado: (2014)

Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023)

Multi‐center evaluation of the highly sensitive Abbott ARCHITECT and Alinity thyroglobulin chemiluminescent microparticle immunoassay
por: Evans, Carol, et al.
Publicado: (2022)

Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection
por: Chew, K.L., et al.
Publicado: (2020)

Sex differences in time course and diagnostic accuracy of GFAP and UCH-L1 in trauma patients with mild traumatic brain injury
por: Papa, Linda, et al.
Publicado: (2023)

Abbott ID now COVID-19 assay performance: a year in review
por: Thwe, Phyu M., et al.
Publicado: (2021)

Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay
por: Perchetti, Garrett A., et al.
Publicado: (2021)

Establishing paediatric reference intervals for thyroid function tests in Croatian population on the Abbott Architect i2000
por: Bokulić, Adriana, et al.
Publicado: (2021)

Omega-3 Fatty Acids and Vitamin D Decrease Plasma T-Tau, GFAP, and UCH-L1 in Experimental Traumatic Brain Injury
por: Scrimgeour, Angus G., et al.
Publicado: (2021)

Performance Evaluation of a Prototype Architect Antibody Assay for Babesia microti
por: Cheng, Kevin, et al.
Publicado: (2018)

Comparison of Abbott LCx Chlamydia trachomatis assay with Gen-Probe PACE2 and culture.
por: Young, D C, et al.
Publicado: (2000)

Effects of age and time since injury on traumatic brain injury blood biomarkers: a TRACK-TBI study
por: Gardner, Raquel C, et al.
Publicado: (2022)

Evaluating glial and neuronal blood biomarkers GFAP and UCH-L1 as gradients of brain injury in concussive, subconcussive and non-concussive trauma: a prospective cohort study
por: Papa, Linda, et al.
Publicado: (2019)

Evaluation of the Abbott Real Time HCV genotype II assay for Hepatitis C virus genotyping
por: Sariguzel, Fatma Mutlu, et al.
Publicado: (2015)

Comparison of Roche and Abbott Cytomegalovirus Quantitative PCR Assays in Allogeneic Hematopoetic Cell Transplant Recipients
por: Mckinnon, John, et al.
Publicado: (2017)

Diagnostic performance of the Abbott RealTime MTB assay for tuberculosis diagnosis in people living with HIV
por: Saavedra, Belén, et al.
Publicado: (2021)

Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
por: Regan, James, et al.
Publicado: (2022)

Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect
por: Maine, Gabriel N., et al.
Publicado: (2020)

Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T‐cell leukaemia virus type‐1 and type‐2 infection in a London teaching hospital with a large solid organ transplant centre
por: Lee, Nathaniel, et al.
Publicado: (2022)

High Sensitivity Cardiac Troponin Assays – How to Implement them Successfully
por: Korley, Frederick K., et al.
Publicado: (2016)

Evaluation of the Aptima HBV Quant Assay Compared to Abbott RealTime M2000 HBV Quant Assay and Procleix Ultrio Plus dHBV Assay in Plasma Samples
por: Yan, Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6qnh8b0rna29b3e3dtgvk0fc56